Shenzhen Kangtai Biological Products Co Ltd Cash Flow Conversion Efficiency
Shenzhen Kangtai Biological Products Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shenzhen Kangtai Biological Products Co Ltd (300601) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥405.44 Million ≈ $59.33 Million USD) by net assets (CN¥9.61 Billion ≈ $1.41 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shenzhen Kangtai Biological Products Co Ltd (2012–2025)
Cash flow conversion efficiency of Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2025. This chart illustrates how Shenzhen Kangtai Biological Products Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shenzhen Kangtai Biological Products Co stock quote for real-time trading data and today's change.
Shenzhen Kangtai Biological Products Co Ltd Cash Flow Conversion Ratio Explained
Shenzhen Kangtai Biological Products Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shenzhen Kangtai Biological Products Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenzhen Kangtai Biological Products Co Ltd ranked by their cash flow conversion efficiency. Also see Shenzhen Kangtai Biological Products Co market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arion banki hf
ST:ARION-SDB
|
0.040x |
|
AvidXchange Holdings Inc
NASDAQ:AVDX
|
0.034x |
|
Hanwha Life
KO:088350
|
0.068x |
|
Formula Systems 1985 Ltd ADR
NASDAQ:FORTY
|
0.009x |
|
Monadelphous Group Ltd
AU:MND
|
0.130x |
|
BHP Group Limited
LSE:BHP
|
0.205x |
|
HUISHANG BK CORP. H YC1
F:HB8
|
N/A |
|
Centuri Holdings, Inc.
NYSE:CTRI
|
0.023x |
Annual Cash Flow Conversion Efficiency for Shenzhen Kangtai Biological Products Co Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2025. Review 300601 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥9.63 Billion ≈ $1.41 Billion |
CN¥635.57 Million ≈ $93.00 Million |
0.066x | +5.68% |
| 2024-12-31 | CN¥9.66 Billion ≈ $1.41 Billion |
CN¥603.25 Million ≈ $88.27 Million |
0.062x | -42.33% |
| 2023-12-31 | CN¥9.54 Billion ≈ $1.40 Billion |
CN¥1.03 Billion ≈ $151.18 Million |
0.108x | +78.28% |
| 2022-12-31 | CN¥8.99 Billion ≈ $1.31 Billion |
CN¥545.70 Million ≈ $79.85 Million |
0.061x | -66.31% |
| 2021-12-31 | CN¥9.17 Billion ≈ $1.34 Billion |
CN¥1.65 Billion ≈ $241.78 Million |
0.180x | +205.85% |
| 2020-12-31 | CN¥7.46 Billion ≈ $1.09 Billion |
CN¥439.85 Million ≈ $64.36 Million |
0.059x | -67.90% |
| 2019-12-31 | CN¥2.75 Billion ≈ $403.03 Million |
CN¥505.70 Million ≈ $74.00 Million |
0.184x | +0.25% |
| 2018-12-31 | CN¥1.84 Billion ≈ $268.83 Million |
CN¥336.48 Million ≈ $49.24 Million |
0.183x | +27.39% |
| 2017-12-31 | CN¥1.07 Billion ≈ $156.72 Million |
CN¥153.98 Million ≈ $22.53 Million |
0.144x | +34.92% |
| 2016-12-31 | CN¥735.00 Million ≈ $107.55 Million |
CN¥78.32 Million ≈ $11.46 Million |
0.107x | -75.18% |
| 2015-12-31 | CN¥647.12 Million ≈ $94.69 Million |
CN¥277.85 Million ≈ $40.66 Million |
0.429x | +123.70% |
| 2014-12-31 | CN¥583.81 Million ≈ $85.43 Million |
CN¥112.06 Million ≈ $16.40 Million |
0.192x | +170.74% |
| 2013-12-31 | CN¥372.17 Million ≈ $54.46 Million |
CN¥26.38 Million ≈ $3.86 Million |
0.071x | +482.01% |
| 2012-12-31 | CN¥431.21 Million ≈ $63.10 Million |
CN¥5.25 Million ≈ $768.62K |
0.012x | -- |
About Shenzhen Kangtai Biological Products Co Ltd
Shenzhen Kangtai Biological Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of human vaccines in China and internationally. The company offers 13-valent pneumococcal polysaccharide conjugate vaccines (TT/DT); varicella vaccines (freeze-dried); hepatitis B vaccines; 23-valent pneumococcal polysaccharide vaccines; diphtheria tetanus ace… Read more